Global Donafenib Tosylate Supply, Demand and Key Producers, 2026-2032
The global Donafenib Tosylate market size is expected to reach $ 97 million by 2032, rising at a market growth of 5.9% CAGR during the forecast period (2026-2032).
In 2025, global production of donafenib tosilate reached approximately 32,000 units.Donafenib Tosylate is an orally administered small-molecule multi-target tyrosine kinase inhibitor (TKI), primarily used for the treatment of malignant tumors such as hepatocellular carcinoma. It is the tosylate form of donafenib and exerts its effects by inhibiting multiple kinases associated with tumor growth and angiogenesis, including RAF kinases, VEGFR, and PDGFR, thereby blocking tumor cell proliferation and tumor angiogenesis.
Compared with traditional drugs of the same class, donafenib tosylate maintains antitumor activity while achieving improved safety and tolerability to a certain extent through structural optimization. As one of the domestically developed targeted anticancer drugs in China, it has been approved for first-line treatment of advanced hepatocellular carcinoma and demonstrates significant clinical value and promising development prospects.
Donafenib Tosylate, as a domestically developed small-molecule multi-target tyrosine kinase inhibitor in China, is primarily positioned in the hepatocellular carcinoma (HCC) treatment market. Globally, the incidence and mortality of liver cancer remain high, particularly in Asia-Pacific regions such as China, where the large patient population provides a stable and continuously growing market demand for this drug. From a competitive perspective, targeted therapies such as sorafenib and lenvatinib have already captured a certain market share; however, with increasing clinical demands for improved efficacy and safety, next-generation drugs are gaining attention. Clinical studies have demonstrated that donafenib tosylate offers favorable survival benefits and tolerability, giving it a competitive advantage in the first-line treatment setting.
In the Chinese market, government support for innovative drugs, improvements in reimbursement access, and the implementation of centralized procurement policies are expected to enhance drug accessibility and promote market penetration. Meanwhile, with the advancement of precision medicine and the continuous standardization of clinical treatment practices, targeted therapies with differentiated advantages are more likely to gain acceptance among physicians and patients. From a global perspective, the demand for targeted cancer therapies continues to grow; however, entry into mature markets such as Europe and the United States will still require further clinical evidence and regulatory approvals.
This report studies the global Donafenib Tosylate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Donafenib Tosylate and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Donafenib Tosylate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Donafenib Tosylate total production and demand, 2021-2032, (Units)
Global Donafenib Tosylate total production value, 2021-2032, (USD Million)
Global Donafenib Tosylate production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Donafenib Tosylate consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Donafenib Tosylate domestic production, consumption, key domestic manufacturers and share
Global Donafenib Tosylate production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Donafenib Tosylate production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Donafenib Tosylate production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Donafenib Tosylate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Suzhou Zelgen Biopharmaceuticals, Zhejiang Apeloa Kangyu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Donafenib Tosylate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Donafenib Tosylate Market, By Region:
1. How big is the global Donafenib Tosylate market?
2. What is the demand of the global Donafenib Tosylate market?
3. What is the year over year growth of the global Donafenib Tosylate market?
4. What is the production and production value of the global Donafenib Tosylate market?
5. Who are the key producers in the global Donafenib Tosylate market?
6. What are the growth factors driving the market demand?
In 2025, global production of donafenib tosilate reached approximately 32,000 units.Donafenib Tosylate is an orally administered small-molecule multi-target tyrosine kinase inhibitor (TKI), primarily used for the treatment of malignant tumors such as hepatocellular carcinoma. It is the tosylate form of donafenib and exerts its effects by inhibiting multiple kinases associated with tumor growth and angiogenesis, including RAF kinases, VEGFR, and PDGFR, thereby blocking tumor cell proliferation and tumor angiogenesis.
Compared with traditional drugs of the same class, donafenib tosylate maintains antitumor activity while achieving improved safety and tolerability to a certain extent through structural optimization. As one of the domestically developed targeted anticancer drugs in China, it has been approved for first-line treatment of advanced hepatocellular carcinoma and demonstrates significant clinical value and promising development prospects.
Donafenib Tosylate, as a domestically developed small-molecule multi-target tyrosine kinase inhibitor in China, is primarily positioned in the hepatocellular carcinoma (HCC) treatment market. Globally, the incidence and mortality of liver cancer remain high, particularly in Asia-Pacific regions such as China, where the large patient population provides a stable and continuously growing market demand for this drug. From a competitive perspective, targeted therapies such as sorafenib and lenvatinib have already captured a certain market share; however, with increasing clinical demands for improved efficacy and safety, next-generation drugs are gaining attention. Clinical studies have demonstrated that donafenib tosylate offers favorable survival benefits and tolerability, giving it a competitive advantage in the first-line treatment setting.
In the Chinese market, government support for innovative drugs, improvements in reimbursement access, and the implementation of centralized procurement policies are expected to enhance drug accessibility and promote market penetration. Meanwhile, with the advancement of precision medicine and the continuous standardization of clinical treatment practices, targeted therapies with differentiated advantages are more likely to gain acceptance among physicians and patients. From a global perspective, the demand for targeted cancer therapies continues to grow; however, entry into mature markets such as Europe and the United States will still require further clinical evidence and regulatory approvals.
This report studies the global Donafenib Tosylate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Donafenib Tosylate and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Donafenib Tosylate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Donafenib Tosylate total production and demand, 2021-2032, (Units)
Global Donafenib Tosylate total production value, 2021-2032, (USD Million)
Global Donafenib Tosylate production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Donafenib Tosylate consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Donafenib Tosylate domestic production, consumption, key domestic manufacturers and share
Global Donafenib Tosylate production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Donafenib Tosylate production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Donafenib Tosylate production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Donafenib Tosylate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Suzhou Zelgen Biopharmaceuticals, Zhejiang Apeloa Kangyu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Donafenib Tosylate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Donafenib Tosylate Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 200 mg
- 300 mg
- Hospital
- Retail
- Online
- Tablets
- Powder
- Hepatocellular Carcinoma (HCC)
- Inhibit tumor Cell Proliferation
- Inhibit tumor Angiogenesis
- Others
- Suzhou Zelgen Biopharmaceuticals
- Zhejiang Apeloa Kangyu Pharmaceutical
1. How big is the global Donafenib Tosylate market?
2. What is the demand of the global Donafenib Tosylate market?
3. What is the year over year growth of the global Donafenib Tosylate market?
4. What is the production and production value of the global Donafenib Tosylate market?
5. Who are the key producers in the global Donafenib Tosylate market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Donafenib Tosylate Introduction
1.2 World Donafenib Tosylate Supply & Forecast
1.2.1 World Donafenib Tosylate Production Value (2021 & 2025 & 2032)
1.2.2 World Donafenib Tosylate Production (2021-2032)
1.2.3 World Donafenib Tosylate Pricing Trends (2021-2032)
1.3 World Donafenib Tosylate Production by Region (Based on Production Site)
1.3.1 World Donafenib Tosylate Production Value by Region (2021-2032)
1.3.2 World Donafenib Tosylate Production by Region (2021-2032)
1.3.3 World Donafenib Tosylate Average Price by Region (2021-2032)
1.3.4 North America Donafenib Tosylate Production (2021-2032)
1.3.5 Europe Donafenib Tosylate Production (2021-2032)
1.3.6 China Donafenib Tosylate Production (2021-2032)
1.3.7 Japan Donafenib Tosylate Production (2021-2032)
1.3.8 India Donafenib Tosylate Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Donafenib Tosylate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Donafenib Tosylate Major Market Trends
2 DEMAND SUMMARY
2.1 World Donafenib Tosylate Demand (2021-2032)
2.2 World Donafenib Tosylate Consumption by Region
2.2.1 World Donafenib Tosylate Consumption by Region (2021-2026)
2.2.2 World Donafenib Tosylate Consumption Forecast by Region (2027-2032)
2.3 United States Donafenib Tosylate Consumption (2021-2032)
2.4 China Donafenib Tosylate Consumption (2021-2032)
2.5 Europe Donafenib Tosylate Consumption (2021-2032)
2.6 Japan Donafenib Tosylate Consumption (2021-2032)
2.7 South Korea Donafenib Tosylate Consumption (2021-2032)
2.8 ASEAN Donafenib Tosylate Consumption (2021-2032)
2.9 India Donafenib Tosylate Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Donafenib Tosylate Production Value by Manufacturer (2021-2026)
3.2 World Donafenib Tosylate Production by Manufacturer (2021-2026)
3.3 World Donafenib Tosylate Average Price by Manufacturer (2021-2026)
3.4 Donafenib Tosylate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Donafenib Tosylate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Donafenib Tosylate in 2025
3.5.3 Global Concentration Ratios (CR8) for Donafenib Tosylate in 2025
3.6 Donafenib Tosylate Market: Overall Company Footprint Analysis
3.6.1 Donafenib Tosylate Market: Region Footprint
3.6.2 Donafenib Tosylate Market: Company Product Type Footprint
3.6.3 Donafenib Tosylate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Donafenib Tosylate Production Value Comparison
4.1.1 United States VS China: Donafenib Tosylate Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Donafenib Tosylate Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Donafenib Tosylate Production Comparison
4.2.1 United States VS China: Donafenib Tosylate Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Donafenib Tosylate Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Donafenib Tosylate Consumption Comparison
4.3.1 United States VS China: Donafenib Tosylate Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Donafenib Tosylate Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Donafenib Tosylate Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Donafenib Tosylate Production Value (2021-2026)
4.4.3 United States Based Manufacturers Donafenib Tosylate Production (2021-2026)
4.5 China Based Donafenib Tosylate Manufacturers and Market Share
4.5.1 China Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Donafenib Tosylate Production Value (2021-2026)
4.5.3 China Based Manufacturers Donafenib Tosylate Production (2021-2026)
4.6 Rest of World Based Donafenib Tosylate Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Donafenib Tosylate Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Donafenib Tosylate Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Donafenib Tosylate Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 200 mg
5.2.2 300 mg
5.3 Market Segment by Type
5.3.1 World Donafenib Tosylate Production by Type (2021-2032)
5.3.2 World Donafenib Tosylate Production Value by Type (2021-2032)
5.3.3 World Donafenib Tosylate Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Donafenib Tosylate Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channels
6.2.1 Hospital
6.2.2 Retail
6.2.3 Online
6.3 Market Segment by Sales Channels
6.3.1 World Donafenib Tosylate Production by Sales Channels (2021-2032)
6.3.2 World Donafenib Tosylate Production Value by Sales Channels (2021-2032)
6.3.3 World Donafenib Tosylate Average Price by Sales Channels (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Donafenib Tosylate Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Tablets
7.2.2 Powder
7.3 Market Segment by Dosage Form
7.3.1 World Donafenib Tosylate Production by Dosage Form (2021-2032)
7.3.2 World Donafenib Tosylate Production Value by Dosage Form (2021-2032)
7.3.3 World Donafenib Tosylate Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Donafenib Tosylate Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hepatocellular Carcinoma (HCC)
8.2.2 Inhibit tumor Cell Proliferation
8.2.3 Inhibit tumor Angiogenesis
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Donafenib Tosylate Production by Application (2021-2032)
8.3.2 World Donafenib Tosylate Production Value by Application (2021-2032)
8.3.3 World Donafenib Tosylate Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Suzhou Zelgen Biopharmaceuticals
9.1.1 Suzhou Zelgen Biopharmaceuticals Details
9.1.2 Suzhou Zelgen Biopharmaceuticals Major Business
9.1.3 Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Product and Services
9.1.4 Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
9.1.6 Suzhou Zelgen Biopharmaceuticals Competitive Strengths & Weaknesses
9.2 Zhejiang Apeloa Kangyu Pharmaceutical
9.2.1 Zhejiang Apeloa Kangyu Pharmaceutical Details
9.2.2 Zhejiang Apeloa Kangyu Pharmaceutical Major Business
9.2.3 Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Product and Services
9.2.4 Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Zhejiang Apeloa Kangyu Pharmaceutical Recent Developments/Updates
9.2.6 Zhejiang Apeloa Kangyu Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Donafenib Tosylate Industry Chain
10.2 Donafenib Tosylate Upstream Analysis
10.2.1 Donafenib Tosylate Core Raw Materials
10.2.2 Main Manufacturers of Donafenib Tosylate Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Donafenib Tosylate Production Mode
10.6 Donafenib Tosylate Procurement Model
10.7 Donafenib Tosylate Industry Sales Model and Sales Channels
10.7.1 Donafenib Tosylate Sales Model
10.7.2 Donafenib Tosylate Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Donafenib Tosylate Introduction
1.2 World Donafenib Tosylate Supply & Forecast
1.2.1 World Donafenib Tosylate Production Value (2021 & 2025 & 2032)
1.2.2 World Donafenib Tosylate Production (2021-2032)
1.2.3 World Donafenib Tosylate Pricing Trends (2021-2032)
1.3 World Donafenib Tosylate Production by Region (Based on Production Site)
1.3.1 World Donafenib Tosylate Production Value by Region (2021-2032)
1.3.2 World Donafenib Tosylate Production by Region (2021-2032)
1.3.3 World Donafenib Tosylate Average Price by Region (2021-2032)
1.3.4 North America Donafenib Tosylate Production (2021-2032)
1.3.5 Europe Donafenib Tosylate Production (2021-2032)
1.3.6 China Donafenib Tosylate Production (2021-2032)
1.3.7 Japan Donafenib Tosylate Production (2021-2032)
1.3.8 India Donafenib Tosylate Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Donafenib Tosylate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Donafenib Tosylate Major Market Trends
2 DEMAND SUMMARY
2.1 World Donafenib Tosylate Demand (2021-2032)
2.2 World Donafenib Tosylate Consumption by Region
2.2.1 World Donafenib Tosylate Consumption by Region (2021-2026)
2.2.2 World Donafenib Tosylate Consumption Forecast by Region (2027-2032)
2.3 United States Donafenib Tosylate Consumption (2021-2032)
2.4 China Donafenib Tosylate Consumption (2021-2032)
2.5 Europe Donafenib Tosylate Consumption (2021-2032)
2.6 Japan Donafenib Tosylate Consumption (2021-2032)
2.7 South Korea Donafenib Tosylate Consumption (2021-2032)
2.8 ASEAN Donafenib Tosylate Consumption (2021-2032)
2.9 India Donafenib Tosylate Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Donafenib Tosylate Production Value by Manufacturer (2021-2026)
3.2 World Donafenib Tosylate Production by Manufacturer (2021-2026)
3.3 World Donafenib Tosylate Average Price by Manufacturer (2021-2026)
3.4 Donafenib Tosylate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Donafenib Tosylate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Donafenib Tosylate in 2025
3.5.3 Global Concentration Ratios (CR8) for Donafenib Tosylate in 2025
3.6 Donafenib Tosylate Market: Overall Company Footprint Analysis
3.6.1 Donafenib Tosylate Market: Region Footprint
3.6.2 Donafenib Tosylate Market: Company Product Type Footprint
3.6.3 Donafenib Tosylate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Donafenib Tosylate Production Value Comparison
4.1.1 United States VS China: Donafenib Tosylate Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Donafenib Tosylate Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Donafenib Tosylate Production Comparison
4.2.1 United States VS China: Donafenib Tosylate Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Donafenib Tosylate Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Donafenib Tosylate Consumption Comparison
4.3.1 United States VS China: Donafenib Tosylate Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Donafenib Tosylate Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Donafenib Tosylate Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Donafenib Tosylate Production Value (2021-2026)
4.4.3 United States Based Manufacturers Donafenib Tosylate Production (2021-2026)
4.5 China Based Donafenib Tosylate Manufacturers and Market Share
4.5.1 China Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Donafenib Tosylate Production Value (2021-2026)
4.5.3 China Based Manufacturers Donafenib Tosylate Production (2021-2026)
4.6 Rest of World Based Donafenib Tosylate Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Donafenib Tosylate Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Donafenib Tosylate Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Donafenib Tosylate Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 200 mg
5.2.2 300 mg
5.3 Market Segment by Type
5.3.1 World Donafenib Tosylate Production by Type (2021-2032)
5.3.2 World Donafenib Tosylate Production Value by Type (2021-2032)
5.3.3 World Donafenib Tosylate Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Donafenib Tosylate Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channels
6.2.1 Hospital
6.2.2 Retail
6.2.3 Online
6.3 Market Segment by Sales Channels
6.3.1 World Donafenib Tosylate Production by Sales Channels (2021-2032)
6.3.2 World Donafenib Tosylate Production Value by Sales Channels (2021-2032)
6.3.3 World Donafenib Tosylate Average Price by Sales Channels (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Donafenib Tosylate Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Tablets
7.2.2 Powder
7.3 Market Segment by Dosage Form
7.3.1 World Donafenib Tosylate Production by Dosage Form (2021-2032)
7.3.2 World Donafenib Tosylate Production Value by Dosage Form (2021-2032)
7.3.3 World Donafenib Tosylate Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Donafenib Tosylate Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hepatocellular Carcinoma (HCC)
8.2.2 Inhibit tumor Cell Proliferation
8.2.3 Inhibit tumor Angiogenesis
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Donafenib Tosylate Production by Application (2021-2032)
8.3.2 World Donafenib Tosylate Production Value by Application (2021-2032)
8.3.3 World Donafenib Tosylate Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Suzhou Zelgen Biopharmaceuticals
9.1.1 Suzhou Zelgen Biopharmaceuticals Details
9.1.2 Suzhou Zelgen Biopharmaceuticals Major Business
9.1.3 Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Product and Services
9.1.4 Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
9.1.6 Suzhou Zelgen Biopharmaceuticals Competitive Strengths & Weaknesses
9.2 Zhejiang Apeloa Kangyu Pharmaceutical
9.2.1 Zhejiang Apeloa Kangyu Pharmaceutical Details
9.2.2 Zhejiang Apeloa Kangyu Pharmaceutical Major Business
9.2.3 Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Product and Services
9.2.4 Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Zhejiang Apeloa Kangyu Pharmaceutical Recent Developments/Updates
9.2.6 Zhejiang Apeloa Kangyu Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Donafenib Tosylate Industry Chain
10.2 Donafenib Tosylate Upstream Analysis
10.2.1 Donafenib Tosylate Core Raw Materials
10.2.2 Main Manufacturers of Donafenib Tosylate Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Donafenib Tosylate Production Mode
10.6 Donafenib Tosylate Procurement Model
10.7 Donafenib Tosylate Industry Sales Model and Sales Channels
10.7.1 Donafenib Tosylate Sales Model
10.7.2 Donafenib Tosylate Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Donafenib Tosylate Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Donafenib Tosylate Production Value by Region (2021-2026) & (USD Million)
Table 3. World Donafenib Tosylate Production Value by Region (2027-2032) & (USD Million)
Table 4. World Donafenib Tosylate Production Value Market Share by Region (2021-2026)
Table 5. World Donafenib Tosylate Production Value Market Share by Region (2027-2032)
Table 6. World Donafenib Tosylate Production by Region (2021-2026) & (Units)
Table 7. World Donafenib Tosylate Production by Region (2027-2032) & (Units)
Table 8. World Donafenib Tosylate Production Market Share by Region (2021-2026)
Table 9. World Donafenib Tosylate Production Market Share by Region (2027-2032)
Table 10. World Donafenib Tosylate Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Donafenib Tosylate Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Donafenib Tosylate Major Market Trends
Table 13. World Donafenib Tosylate Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Donafenib Tosylate Consumption by Region (2021-2026) & (Units)
Table 15. World Donafenib Tosylate Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Donafenib Tosylate Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Donafenib Tosylate Producers in 2025
Table 18. World Donafenib Tosylate Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Donafenib Tosylate Producers in 2025
Table 20. World Donafenib Tosylate Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Donafenib Tosylate Company Evaluation Quadrant
Table 22. World Donafenib Tosylate Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Donafenib Tosylate Production Site of Key Manufacturer
Table 24. Donafenib Tosylate Market: Company Product Type Footprint
Table 25. Donafenib Tosylate Market: Company Product Application Footprint
Table 26. Donafenib Tosylate Competitive Factors
Table 27. Donafenib Tosylate New Entrant and Capacity Expansion Plans
Table 28. Donafenib Tosylate Mergers & Acquisitions Activity
Table 29. United States VS China Donafenib Tosylate Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Donafenib Tosylate Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Donafenib Tosylate Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Donafenib Tosylate Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Donafenib Tosylate Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Donafenib Tosylate Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Donafenib Tosylate Production Market Share (2021-2026)
Table 37. China Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Donafenib Tosylate Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Donafenib Tosylate Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Donafenib Tosylate Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Donafenib Tosylate Production Market Share (2021-2026)
Table 42. Rest of World Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Donafenib Tosylate Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Donafenib Tosylate Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Donafenib Tosylate Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Donafenib Tosylate Production Market Share (2021-2026)
Table 47. World Donafenib Tosylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Donafenib Tosylate Production by Type (2021-2026) & (Units)
Table 49. World Donafenib Tosylate Production by Type (2027-2032) & (Units)
Table 50. World Donafenib Tosylate Production Value by Type (2021-2026) & (USD Million)
Table 51. World Donafenib Tosylate Production Value by Type (2027-2032) & (USD Million)
Table 52. World Donafenib Tosylate Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Donafenib Tosylate Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Donafenib Tosylate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 55. World Donafenib Tosylate Production by Sales Channels (2021-2026) & (Units)
Table 56. World Donafenib Tosylate Production by Sales Channels (2027-2032) & (Units)
Table 57. World Donafenib Tosylate Production Value by Sales Channels (2021-2026) & (USD Million)
Table 58. World Donafenib Tosylate Production Value by Sales Channels (2027-2032) & (USD Million)
Table 59. World Donafenib Tosylate Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 60. World Donafenib Tosylate Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 61. World Donafenib Tosylate Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Donafenib Tosylate Production by Dosage Form (2021-2026) & (Units)
Table 63. World Donafenib Tosylate Production by Dosage Form (2027-2032) & (Units)
Table 64. World Donafenib Tosylate Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Donafenib Tosylate Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Donafenib Tosylate Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 67. World Donafenib Tosylate Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 68. World Donafenib Tosylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Donafenib Tosylate Production by Application (2021-2026) & (Units)
Table 70. World Donafenib Tosylate Production by Application (2027-2032) & (Units)
Table 71. World Donafenib Tosylate Production Value by Application (2021-2026) & (USD Million)
Table 72. World Donafenib Tosylate Production Value by Application (2027-2032) & (USD Million)
Table 73. World Donafenib Tosylate Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Donafenib Tosylate Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Suzhou Zelgen Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Suzhou Zelgen Biopharmaceuticals Major Business
Table 77. Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Product and Services
Table 78. Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
Table 80. Suzhou Zelgen Biopharmaceuticals Competitive Strengths & Weaknesses
Table 81. Zhejiang Apeloa Kangyu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Zhejiang Apeloa Kangyu Pharmaceutical Major Business
Table 83. Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Product and Services
Table 84. Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Zhejiang Apeloa Kangyu Pharmaceutical Recent Developments/Updates
Table 86. Zhejiang Apeloa Kangyu Pharmaceutical Competitive Strengths & Weaknesses
Table 87. Global Key Players of Donafenib Tosylate Upstream (Raw Materials)
Table 88. Global Donafenib Tosylate Typical Customers
Table 89. Donafenib Tosylate Typical Distributors
Table 1. World Donafenib Tosylate Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Donafenib Tosylate Production Value by Region (2021-2026) & (USD Million)
Table 3. World Donafenib Tosylate Production Value by Region (2027-2032) & (USD Million)
Table 4. World Donafenib Tosylate Production Value Market Share by Region (2021-2026)
Table 5. World Donafenib Tosylate Production Value Market Share by Region (2027-2032)
Table 6. World Donafenib Tosylate Production by Region (2021-2026) & (Units)
Table 7. World Donafenib Tosylate Production by Region (2027-2032) & (Units)
Table 8. World Donafenib Tosylate Production Market Share by Region (2021-2026)
Table 9. World Donafenib Tosylate Production Market Share by Region (2027-2032)
Table 10. World Donafenib Tosylate Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Donafenib Tosylate Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Donafenib Tosylate Major Market Trends
Table 13. World Donafenib Tosylate Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Donafenib Tosylate Consumption by Region (2021-2026) & (Units)
Table 15. World Donafenib Tosylate Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Donafenib Tosylate Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Donafenib Tosylate Producers in 2025
Table 18. World Donafenib Tosylate Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Donafenib Tosylate Producers in 2025
Table 20. World Donafenib Tosylate Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Donafenib Tosylate Company Evaluation Quadrant
Table 22. World Donafenib Tosylate Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Donafenib Tosylate Production Site of Key Manufacturer
Table 24. Donafenib Tosylate Market: Company Product Type Footprint
Table 25. Donafenib Tosylate Market: Company Product Application Footprint
Table 26. Donafenib Tosylate Competitive Factors
Table 27. Donafenib Tosylate New Entrant and Capacity Expansion Plans
Table 28. Donafenib Tosylate Mergers & Acquisitions Activity
Table 29. United States VS China Donafenib Tosylate Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Donafenib Tosylate Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Donafenib Tosylate Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Donafenib Tosylate Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Donafenib Tosylate Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Donafenib Tosylate Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Donafenib Tosylate Production Market Share (2021-2026)
Table 37. China Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Donafenib Tosylate Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Donafenib Tosylate Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Donafenib Tosylate Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Donafenib Tosylate Production Market Share (2021-2026)
Table 42. Rest of World Based Donafenib Tosylate Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Donafenib Tosylate Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Donafenib Tosylate Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Donafenib Tosylate Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Donafenib Tosylate Production Market Share (2021-2026)
Table 47. World Donafenib Tosylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Donafenib Tosylate Production by Type (2021-2026) & (Units)
Table 49. World Donafenib Tosylate Production by Type (2027-2032) & (Units)
Table 50. World Donafenib Tosylate Production Value by Type (2021-2026) & (USD Million)
Table 51. World Donafenib Tosylate Production Value by Type (2027-2032) & (USD Million)
Table 52. World Donafenib Tosylate Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Donafenib Tosylate Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Donafenib Tosylate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 55. World Donafenib Tosylate Production by Sales Channels (2021-2026) & (Units)
Table 56. World Donafenib Tosylate Production by Sales Channels (2027-2032) & (Units)
Table 57. World Donafenib Tosylate Production Value by Sales Channels (2021-2026) & (USD Million)
Table 58. World Donafenib Tosylate Production Value by Sales Channels (2027-2032) & (USD Million)
Table 59. World Donafenib Tosylate Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 60. World Donafenib Tosylate Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 61. World Donafenib Tosylate Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Donafenib Tosylate Production by Dosage Form (2021-2026) & (Units)
Table 63. World Donafenib Tosylate Production by Dosage Form (2027-2032) & (Units)
Table 64. World Donafenib Tosylate Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Donafenib Tosylate Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Donafenib Tosylate Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 67. World Donafenib Tosylate Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 68. World Donafenib Tosylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Donafenib Tosylate Production by Application (2021-2026) & (Units)
Table 70. World Donafenib Tosylate Production by Application (2027-2032) & (Units)
Table 71. World Donafenib Tosylate Production Value by Application (2021-2026) & (USD Million)
Table 72. World Donafenib Tosylate Production Value by Application (2027-2032) & (USD Million)
Table 73. World Donafenib Tosylate Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Donafenib Tosylate Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Suzhou Zelgen Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Suzhou Zelgen Biopharmaceuticals Major Business
Table 77. Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Product and Services
Table 78. Suzhou Zelgen Biopharmaceuticals Donafenib Tosylate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
Table 80. Suzhou Zelgen Biopharmaceuticals Competitive Strengths & Weaknesses
Table 81. Zhejiang Apeloa Kangyu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Zhejiang Apeloa Kangyu Pharmaceutical Major Business
Table 83. Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Product and Services
Table 84. Zhejiang Apeloa Kangyu Pharmaceutical Donafenib Tosylate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Zhejiang Apeloa Kangyu Pharmaceutical Recent Developments/Updates
Table 86. Zhejiang Apeloa Kangyu Pharmaceutical Competitive Strengths & Weaknesses
Table 87. Global Key Players of Donafenib Tosylate Upstream (Raw Materials)
Table 88. Global Donafenib Tosylate Typical Customers
Table 89. Donafenib Tosylate Typical Distributors
LIST OF FIGURES
Figure 1. Donafenib Tosylate Picture
Figure 2. World Donafenib Tosylate Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Donafenib Tosylate Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Donafenib Tosylate Production (2021-2032) & (Units)
Figure 5. World Donafenib Tosylate Average Price (2021-2032) & (US$/Unit)
Figure 6. World Donafenib Tosylate Production Value Market Share by Region (2021-2032)
Figure 7. World Donafenib Tosylate Production Market Share by Region (2021-2032)
Figure 8. North America Donafenib Tosylate Production (2021-2032) & (Units)
Figure 9. Europe Donafenib Tosylate Production (2021-2032) & (Units)
Figure 10. China Donafenib Tosylate Production (2021-2032) & (Units)
Figure 11. Japan Donafenib Tosylate Production (2021-2032) & (Units)
Figure 12. India Donafenib Tosylate Production (2021-2032) & (Units)
Figure 13. Donafenib Tosylate Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 16. World Donafenib Tosylate Consumption Market Share by Region (2021-2032)
Figure 17. United States Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 18. China Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 19. Europe Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 20. Japan Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 21. South Korea Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 22. ASEAN Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 23. India Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Donafenib Tosylate by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Donafenib Tosylate Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Donafenib Tosylate Markets in 2025
Figure 27. United States VS China: Donafenib Tosylate Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Donafenib Tosylate Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Donafenib Tosylate Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Donafenib Tosylate Production Market Share 2025
Figure 31. China Based Manufacturers Donafenib Tosylate Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Donafenib Tosylate Production Market Share 2025
Figure 33. World Donafenib Tosylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Donafenib Tosylate Production Value Market Share by Type in 2025
Figure 35. 200 mg
Figure 36. 300 mg
Figure 37. World Donafenib Tosylate Production Market Share by Type (2021-2032)
Figure 38. World Donafenib Tosylate Production Value Market Share by Type (2021-2032)
Figure 39. World Donafenib Tosylate Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Donafenib Tosylate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 41. World Donafenib Tosylate Production Value Market Share by Sales Channels in 2025
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World Donafenib Tosylate Production Market Share by Sales Channels (2021-2032)
Figure 46. World Donafenib Tosylate Production Value Market Share by Sales Channels (2021-2032)
Figure 47. World Donafenib Tosylate Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 48. World Donafenib Tosylate Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 49. World Donafenib Tosylate Production Value Market Share by Dosage Form in 2025
Figure 50.Tablets
Figure 51. Powder
Figure 52. World Donafenib Tosylate Production Market Share by Dosage Form (2021-2032)
Figure 53. World Donafenib Tosylate Production Value Market Share by Dosage Form (2021-2032)
Figure 54. World Donafenib Tosylate Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 55. World Donafenib Tosylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Donafenib Tosylate Production Value Market Share by Application in 2025
Figure 57. Hepatocellular Carcinoma (HCC)
Figure 58. Inhibit tumor Cell Proliferation
Figure 59. Inhibit tumor Angiogenesis
Figure 60. Others
Figure 61. World Donafenib Tosylate Production Market Share by Application (2021-2032)
Figure 62. World Donafenib Tosylate Production Value Market Share by Application (2021-2032)
Figure 63. World Donafenib Tosylate Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Donafenib Tosylate Industry Chain
Figure 65. Donafenib Tosylate Procurement Model
Figure 66. Donafenib Tosylate Sales Model
Figure 67. Donafenib Tosylate Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Donafenib Tosylate Picture
Figure 2. World Donafenib Tosylate Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Donafenib Tosylate Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Donafenib Tosylate Production (2021-2032) & (Units)
Figure 5. World Donafenib Tosylate Average Price (2021-2032) & (US$/Unit)
Figure 6. World Donafenib Tosylate Production Value Market Share by Region (2021-2032)
Figure 7. World Donafenib Tosylate Production Market Share by Region (2021-2032)
Figure 8. North America Donafenib Tosylate Production (2021-2032) & (Units)
Figure 9. Europe Donafenib Tosylate Production (2021-2032) & (Units)
Figure 10. China Donafenib Tosylate Production (2021-2032) & (Units)
Figure 11. Japan Donafenib Tosylate Production (2021-2032) & (Units)
Figure 12. India Donafenib Tosylate Production (2021-2032) & (Units)
Figure 13. Donafenib Tosylate Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 16. World Donafenib Tosylate Consumption Market Share by Region (2021-2032)
Figure 17. United States Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 18. China Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 19. Europe Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 20. Japan Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 21. South Korea Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 22. ASEAN Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 23. India Donafenib Tosylate Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Donafenib Tosylate by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Donafenib Tosylate Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Donafenib Tosylate Markets in 2025
Figure 27. United States VS China: Donafenib Tosylate Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Donafenib Tosylate Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Donafenib Tosylate Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Donafenib Tosylate Production Market Share 2025
Figure 31. China Based Manufacturers Donafenib Tosylate Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Donafenib Tosylate Production Market Share 2025
Figure 33. World Donafenib Tosylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Donafenib Tosylate Production Value Market Share by Type in 2025
Figure 35. 200 mg
Figure 36. 300 mg
Figure 37. World Donafenib Tosylate Production Market Share by Type (2021-2032)
Figure 38. World Donafenib Tosylate Production Value Market Share by Type (2021-2032)
Figure 39. World Donafenib Tosylate Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Donafenib Tosylate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 41. World Donafenib Tosylate Production Value Market Share by Sales Channels in 2025
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World Donafenib Tosylate Production Market Share by Sales Channels (2021-2032)
Figure 46. World Donafenib Tosylate Production Value Market Share by Sales Channels (2021-2032)
Figure 47. World Donafenib Tosylate Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 48. World Donafenib Tosylate Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 49. World Donafenib Tosylate Production Value Market Share by Dosage Form in 2025
Figure 50.Tablets
Figure 51. Powder
Figure 52. World Donafenib Tosylate Production Market Share by Dosage Form (2021-2032)
Figure 53. World Donafenib Tosylate Production Value Market Share by Dosage Form (2021-2032)
Figure 54. World Donafenib Tosylate Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 55. World Donafenib Tosylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Donafenib Tosylate Production Value Market Share by Application in 2025
Figure 57. Hepatocellular Carcinoma (HCC)
Figure 58. Inhibit tumor Cell Proliferation
Figure 59. Inhibit tumor Angiogenesis
Figure 60. Others
Figure 61. World Donafenib Tosylate Production Market Share by Application (2021-2032)
Figure 62. World Donafenib Tosylate Production Value Market Share by Application (2021-2032)
Figure 63. World Donafenib Tosylate Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Donafenib Tosylate Industry Chain
Figure 65. Donafenib Tosylate Procurement Model
Figure 66. Donafenib Tosylate Sales Model
Figure 67. Donafenib Tosylate Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
